280 related articles for article (PubMed ID: 22375527)
1. The IL-23/IL-17 pathway in inflammatory bowel disease.
Geremia A; Jewell DP
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):223-37. PubMed ID: 22375527
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
3. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
Sartor RB
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
[TBL] [Abstract][Full Text] [Related]
4. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
[TBL] [Abstract][Full Text] [Related]
5. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
6. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases.
Chassaing B; Darfeuille-Michaud A
Gastroenterology; 2011 May; 140(6):1720-28. PubMed ID: 21530738
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis of inflammatory bowel disease: current concepts.
Bamias G; Cominelli F
Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
[TBL] [Abstract][Full Text] [Related]
8. Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B.
Huang Z; van Velkinburgh JC; Ni B; Wu Y
Liver Int; 2012 Jul; 32(6):894-901. PubMed ID: 22340646
[TBL] [Abstract][Full Text] [Related]
9. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
10. Interaction of genetic, environmental and immune factors in the pathogenesis of inflammatory bowel diseases.
Chowers Y
Isr Med Assoc J; 2002 Oct; 4(10):815-7. PubMed ID: 12389349
[No Abstract] [Full Text] [Related]
11. Role of the IL-23/IL-17 axis in Crohn's disease.
Siakavellas SI; Bamias G
Discov Med; 2012 Oct; 14(77):253-62. PubMed ID: 23114581
[TBL] [Abstract][Full Text] [Related]
12. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
Reuter BK; Pizarro TT
Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
[TBL] [Abstract][Full Text] [Related]
13. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
15. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
Furfaro F; Gilardi D; Allocca M; Cicerone C; Correale C; Fiorino G; Danese S
Expert Rev Clin Immunol; 2017 May; 13(5):457-467. PubMed ID: 28067059
[TBL] [Abstract][Full Text] [Related]
16. Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection.
Campos N; Magro F; Castro AR; Cabral J; Rodrigues P; Silva R; Appelberg R; Rodrigues S; Lopes S; Macedo G; Sarmento A
Immunobiology; 2011 Aug; 216(8):961-70. PubMed ID: 21269730
[TBL] [Abstract][Full Text] [Related]
17. Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease.
Rosenstiel P; Sina C; Franke A; Schreiber S
Semin Immunol; 2009 Dec; 21(6):334-45. PubMed ID: 19926490
[TBL] [Abstract][Full Text] [Related]
18. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.
Nakajima K
J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845
[TBL] [Abstract][Full Text] [Related]
19. [Intestinal flora and Crohn's disease].
Desreumaux P; Colombel JF
Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease: beyond the boundaries of the bowel.
Actis GC; Rosina F; Mackay IR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
